BioCrude Technologies USA, Inc.: 10-Q filed 2017-09-12
What BioCrude Technologies USA, Inc. reported in its quarterly report filed 2017-09-12 (fiscal Q2 2017): 12 published measures, 38 facts as tagged in accession 0001615774-17-005016.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2017-09-12
- Fiscal period
- fiscal Q2 2017
- Accession
- 0001615774-17-005016 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioCrude Technologies USA, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 426 | USD | |
| At 2016-12-31 | 168 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 399,680 | USD | |
| At 2016-12-31 | 331,096 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -399,254 | USD | |
| At 2016-12-31 | -330,928 | USD | |
| At 2015-12-31 | -238,438 | USD |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | -6,412,927 | USD | |
| At 2016-12-31 | -6,344,158 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-01-01 to 2017-06-30 | 4,112 | USD | 181 |
| 2016-01-01 to 2016-06-30 | 22,373 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -21,443 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -64,075 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -56,309 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -97,495 | USD | 182 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 2,199 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 4,694 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 1,246 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 3,318 | USD | 182 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 21,443 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 64,075 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 56,309 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 97,495 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2017-06-30 | 49,807,453 | shares | |
| At 2016-12-31 | 49,805,103 | shares |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -23,642 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -68,769 | USD | 181 |
| 2016-01-01 to 2016-12-31 | -190,622 | USD | 366 |
| 2016-04-01 to 2016-06-30 | -57,555 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -100,813 | USD | 182 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | -26,401 | USD | 91 |
| 2017-01-01 to 2017-06-30 | -72,438 | USD | 181 |
| 2016-04-01 to 2016-06-30 | -57,567 | USD | 91 |
| 2016-01-01 to 2016-06-30 | -93,221 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-04-01 to 2017-06-30 | 21,443 | USD | 91 |
| 2017-01-01 to 2017-06-30 | 64,075 | USD | 181 |
| 2016-04-01 to 2016-06-30 | 56,309 | USD | 91 |
| 2016-01-01 to 2016-06-30 | 97,495 | USD | 182 |
Inspect the source
- Entity
- BioCrude Technologies USA, Inc. / CIK 0001690384
- Captured
- 2026-09-21T17:24:05.073Z
- SEC response SHA-256
89c76d3d401fe6afb068748f997c9daeba79c1147b3d9c59f4ddc55dd1617a16
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001690384.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))